Jeff BrownEditor, The Bleeding Edge, The Near Future Report, Exponential Tech Investor, Day One Investor, and Brownstone Unlimited

Jeff Brown

Jeff Brown is the founder and chief investment analyst for Brownstone Research. Before founding Brownstone Research, Jeff spent 25 years as a high-technology executive. He worked as an executive level for some of the best technology companies in the world, like Qualcomm, NXP Semiconductors, and Juniper Networks.

As an active and successful angel investor in early stage technology companies, he has access to information the public never sees. He is on the front line, in the field, seeing things months, if not years, before the mass market becomes aware.

Jeff has a wide range of technology industry experience. From semiconductors to mobility… to broadcasting and video technology… to technology infrastructure… to IT networking and security… to automotive and even consumer electronics… he’s done it all.

He has built organizations from the ground up and run divisions of companies generating hundreds of millions in revenue a year.

Though he was born, educated, and began his career in America, he spent two decades living and working in international markets, with much of that time spent in Tokyo, Japan. That gives him a unique global perspective on business, investing, and analysis.

Jeff earned his undergraduate degree in aeronautical and astronautical engineering from Purdue University. He also earned his master’s degree in management from the London Business School. Jeff is also an alumnus of Yale University’s School of Management.

In addition to formal degrees, Jeff has professional certificates from MIT, Stanford, UC Berkeley’s School of Law, and the National University of Singapore.

Jeff is an active board member and adviser to several companies and an active angel investor.

Today, Jeff uses his technology, business, finance, and investing expertise to help everyday investors discover companies on the verge of exponential growth.

Jeff Brown’s Research Services

The Bleeding Edge

Learn more

The Near Future Report

Learn more

Exponential Tech Investor

Learn more

Day One Investor

Learn more

Brownstone Unlimited

Learn more

CRISPR Is Now Targeting Vitamin Deficiencies

CRISPR is like software programming for DNA, and U.K.-based researchers just demonstrated how to use it to stop tomatoes from converting their natural vitamin D into cholesterol. Jeff sees this as a huge development…

A New Strategy for This Volatile Market

With the potential for more aggressive interest-rate hikes and rising inflation, it makes sense to approach this market with...

These Investments Go Against the Crowd

Markets have looked dismal lately. Many people’s brokerages are getting maimed as stocks drop. Yet for those few that...

DeSoc Whitepaper Could Lead to China-Style Social Credits

A recent Bleeding Edge topic, DeSoc, would provide a way to document and validate our key credentials. But our...

“Real” Inflation Is Much Higher Than the CPI

Volatility is scaring investors away from potentially groundbreaking investments, so where should we turn next? Jeff Brown has been...

TSMC’s CapEx Is Hitting Record Levels

With all of the fear in the market, Jeff has been keeping a close eye on indicators that allow...

How to Invest Like a Contrarian

While the stock market remains volatile, investors are on the hunt for any kind of “safe” investment they can...